|
End-of-day quote
Egyptian Exchange
28/09/2026
|
5-day change | 1st Jan Change | ||
| 1.460 EGP | -2.01% |
|
-9.88% | +28.07% |
| 05-17 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| 05-17 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 5B 95.87M 84.32M 79.74M 72.32M 136M 9.2B 137M 955M 369M 4.7B 360M 352M 15.09B | P/E 2026 * |
24.3x | P/E 2027 * | 16.2x |
|---|---|---|---|---|---|
| Enterprise Value | 4.92B 94.34M 82.98M 78.46M 71.17M 134M 9.06B 134M 939M 363M 4.62B 354M 347M 14.85B | EV / Sales 2026 * |
4.13x | EV / Sales 2027 * | 3.15x |
| Free-Float |
30.46% | Yield 2026 * |
2.05% | Yield 2027 * | 2.74% |
| 1 day | -2.01% | ||
| 1 week | -9.88% | ||
| Current month | -2.67% | ||
| 1 month | -2.67% | ||
| 3 months | +23.73% | ||
| 6 months | +5.80% | ||
| Current year | +28.07% |
| 1 week | 1.41 |  | 1.7 |
| 1 month | 1.41 | | 1.81 |
| Current year | 1.02 | | 1.81 |
| 1 year | 0.81 | | 4.11 |
| 3 years | 0.81 | | 4.11 |
| 5 years | 0.81 | | 5.28 |
| 10 years | 0.81 | | 5.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Khaled Kamel
CEO | Chief Executive Officer | - | - |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
Tamer Raouf
SAM | Sales & Marketing | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ahmed El-Nayeb
CHM | Chairman | - | 01/01/2002 |
Tamir Saeed
BRD | Director/Board Member | - | 01/01/2021 |
Norbert Lurz
BRD | Director/Board Member | - | 01/01/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.01% | -9.88% | -50.51% | -44.06% | 95.87M | |
| -1.11% | +0.70% | +62.19% | +119.37% | 1,056B | |
| -2.09% | -0.89% | +46.89% | +71.29% | 655B | |
| -1.52% | -0.51% | +18.24% | +77.01% | 471B | |
| -1.84% | -4.04% | +36.43% | +39.51% | 342B | |
| -0.64% | +3.80% | +22.04% | +28.77% | 277B | |
| -0.80% | -1.88% | +12.14% | +12.00% | 257B | |
| -0.60% | +1.81% | +52.45% | +55.41% | 226B | |
| -1.79% | -1.25% | +33.86% | +101.17% | 189B | |
| -0.37% | -2.90% | -28.51% | -60.97% | 170B | |
| Average | -1.23% | -0.44% | +20.52% | +39.95% | 364.3B | |
| Weighted average by Cap. | -1.27% | +1.04% | +38.45% | +69.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.19B 22.84M 20.09M 19M 17.23M 32.36M 2.19B 32.55M 227M 87.84M 1.12B 85.75M 83.9M 3.6B | 1.55B 29.79M 26.2M 24.77M 22.47M 42.2M 2.86B 42.45M 297M 115M 1.46B 112M 109M 4.69B |
| Net income | 206M 3.95M 3.48M 3.29M 2.98M 5.6M 380M 5.63M 39.37M 15.21M 194M 14.84M 14.52M 622M | 283M 5.43M 4.78M 4.52M 4.1M 7.7M 521M 7.74M 54.09M 20.89M 266M 20.39M 19.95M 855M |
| Net Debt | -79.7M -1.53M -1.35M -1.27M -1.15M -2.17M -147M -2.18M -15.23M -5.88M -74.93M -5.74M -5.62M -241M | -110M -2.11M -1.86M -1.76M -1.59M -2.99M -203M -3.01M -21.02M -8.12M -103M -7.93M -7.76M -332M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/09/26 | EGP 1.460 | -2.01% | 30,443,066 |
| 27/09/26 | EGP 1.490 | -6.29% | 25,427,091 |
| 24/09/26 | EGP 1.590 | -2.45% | 38,671,818 |
| 23/09/26 | EGP 1.630 | -2.98% | 23,193,515 |
| 22/09/26 | EGP 1.680 | +3.70% | 79,510,884 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.460EGP
Average target price
1.570EGP
Spread / Average Target
+7.53%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MCRO Stock
Select your edition
All financial news and data tailored to specific country editions
